XML 40 R58.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Share-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2019
Fair Value of Options Granted
The fair value of options granted is estimated on the date of the grant using an option-pricing model with the following weighted-average assumptions:
 
Years Ended December 31
 
 
2019
 
 
2018
 
 
2017
 
Dividend yields
   
2.39
%    
1.99
%    
1.75
%
Volatility factors of expected market price of common stock
   
28.67
%    
28.60
%    
28.52
%
Risk-free interest rates
   
2.61
%    
2.85
%    
2.42
%
Expected life of options
   
8 years
     
8 years
     
8 years
 
Summary of Status of Non-vested, Restricted and Performance Shares
A summary of the status of Horizon’s
non-vested
restricted and performance shares as of December 31, 2019 are presented below:
 
Shares
 
 
Weighted
Average
Grant Date
Fair Value
 
Non-vested,
beginning of year
   
176,538
    $
 16.90
 
Vested
   
(43,358
)    
11.17
 
Granted
   
84,526
     
16.74
 
Forfeited
   
(4,137
)    
18.23
 
                 
Non-vested,
end of year
   
213,569
     
17.97
 
                 
Stock Options 2003 Plan [Member]  
Summary of Option Activity under 2003 Plan
A summary of option activity under the 2003 Plan as of December 31, 2019, and changes during the year then ended, is presented below:
 
Shares
 
 
Weighted-
Average
Exercise Price
 
 
Weighted-
Average
Remaining
Contractual
Term
 
 
Aggregate
Intrinsic
Value
 
Outstanding, beginning of year
   
21,300
    $
 5.03
     
     
 
Granted
   
—  
     
—  
     
     
 
Exercised
   
(8,625
)    
4.45
     
     
 
Forfeited
   
—  
     
—  
     
     
 
                                 
Outstanding, end of year
   
12,675
     
5.42
     
1.04
    $
172,096
 
                                 
Exercisable, end of year
   
12,675
     
5.42
     
1.04
     
172,096
 
Stock Options 2013 Plan [Member]  
Summary of Option Activity under 2003 Plan
A summary of option activity under the 2013 Plan as of December 31, 2019, and changes during the year then ended, is presented below:
 
Shares
 
 
Weighted-
Average
Exercise Price
 
 
Weighted-
Average
Remaining
Contractual
Term
 
 
Aggregate
Intrinsic
Value
 
Outstanding, beginning of year
   
307,317
    $
 12.28
     
     
 
Granted
   
35,966
     
16.74
     
     
 
Exercised
   
(24,256
)    
9.75
     
     
 
Forfeited
   
(2,250
)    
10.38
     
     
 
                                 
Outstanding, end of year
   
316,777
     
12.99
     
6.37
    $
1,822,924
 
                                 
Exercisable, end of year
   
242,814
     
11.58
     
5.74
     
1,802,010
 
The weighted average grant-date fair value of options granted during the years 2019, 2018 and 2017 was $4.44, $5.54 and $4.83.